Additionally, the expression of other oxLDL receptors, including Sra, Sr-b1, Srec and Lox1, was also determined in murine NAFLD-associated HCCs, and there was no consistent alteration in HFHC mice and tumor tissues (Supplementary Fig. 2G). This evidence concerns the gene SCARF1 and metabolic dysfunction-associated steatotic liver disease.